Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.
CompletedOBSERVATIONAL
Enrollment
120
Participants
Timeline
Start Date
November 17, 2021
Primary Completion Date
January 8, 2023
Study Completion Date
June 8, 2023
Conditions
Oncologic Complications
Trial Locations (1)
27100
Irccs San Matteo Pavia, Pavia
All Listed Sponsors
lead
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
NCT06334744 - Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active. | Biotech Hunter | Biotech Hunter